BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22583735)

  • 1. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis.
    Gargalionis AN; Piperi C; Adamopoulos C; Papavassiliou AG
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1276-89. PubMed ID: 22583735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells.
    Peláez IM; Kalogeropoulou M; Ferraro A; Voulgari A; Pankotai T; Boros I; Pintzas A
    Int J Biochem Cell Biol; 2010 Jun; 42(6):911-20. PubMed ID: 20109579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
    Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
    Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of histone modifications in malignant transformation].
    Gomulak P; Błasiak J
    Postepy Biochem; 2012; 58(3):292-301. PubMed ID: 23373415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetylation in gene regulation.
    Verdone L; Agricola E; Caserta M; Di Mauro E
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
    Cuomo A; Moretti S; Minucci S; Bonaldi T
    Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone modifications as a platform for cancer therapy.
    Espino PS; Drobic B; Dunn KL; Davie JR
    J Cell Biochem; 2005 Apr; 94(6):1088-102. PubMed ID: 15723344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple histone acetylation plays a complex role in the regulation of gene expression.
    Fukuda H; Sano N; Muto S; Horikoshi M
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):190-208. PubMed ID: 16980317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.